CiteFacts · FDA Drug Shortages · FDA source
Bacitracin Ophthalmic Ointment
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Padagis US LLC | Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35) | Unavailable | 06/01/2026 |
Source facts
Grouped generic ingredient: Bacitracin Ophthalmic Ointment · 1 package records · Latest FDA row update: 06/01/2026
Therapeutic categories: Anti-Infective, Ophthalmology
Dosage forms: Ophthalmic Ointment
Routes: Not stated
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.